A summary of an ICER cost-effectiveness analysis published in JMCP found that despite incremental clinical benefits, biologics used to treat asthma have low long-term value for money.
ICER's analysis of biologics used to treat asthma falls short of adequately addressing factors related to patients' health and quality of life, particularly those with severe, uncontrolled asthma, according to this JMCP article by the Asthma and Allergy Foundation of America's CEO.
Collaboration and transparency in the development of cost-effectiveness models can increase the credibility and relevance of these models for local decision making, according to this JMCP article.
A literature review published in JMCP found mixed evidence regarding the use of pharmacogenomic testing to guide cancer treatment. Prioritization of clinically relevant drug-gene associations is critical in determining which tests are beneficial.
A literature review published in JMCP found mixed evidence regarding the use of pharmacogenomic testing to guide cancer treatment. Prioritization of clinically relevant drug-gene associations is critical in determining which tests are beneficial.
Partnership Forum: Implementing value-based reimbursement models for both pharmaceuticals and medical care poses significant challenges and opportunities, and depends on integrated delivery networks (IDNs) to execute the processes and programs. Industry thought leaders convened to discuss the issues.
Partnership Forum: AMCP defined the ideal state for PROs , their importance and systems needed in a previous forum. Here AMCP brought together thought leaders to discuss and identify tactics to achieve the “ideal state.”
AMCP webinar that reviewed proceedings from this Partnership Forum.
AMCP webinar that reviewed proceedings from this Partnership Forum.
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide information on the application of value-based contracts (VBCs) for insulin pricing initiatives. The shift in payment models is expanding beyond the delivery of health care services to encompass models of compensation between payers and biopharmaceutical manufacturers.
AMCP Foundation webinar that discussed highlights from the 7th Annual Research Symposium.
Press Release: Thought leaders representing managed care organizations, providers, patients, biopharmaceutical manufacturers and other stakeholders gathered recently to find solutions to the financial burden of oncology care on patients, while also improving cancer treatment outcomes and advancing the concept of value-based health care.
